MELIOR DISCOVERY

Melior Discovery is a world class provider of in vivo pharmacology services. We evaluate candidate therapeutics in animal models of human disease. The company has established and validated over 80 animal models in an array of therapeutic areas such as inflammation, immunology, diabetes & metabolic syndrome, dermatology, cardiovascular, gastrointestinal, psychiatric, neurological and neurodegenerative disorders. Our expertise, skill level, and the quality of the data that we produce is now widely recognized by scientists throughout the global pharmaceutical and biopharmaceutical industry... More than just a provider of in vivo pharmacology services, Melior is a pioneer of in vivo phenotypic screening and a leader in the area of drug repositioning. Its proprietary thera TRACE® platform enables rapid and cost-effective identification of new therapeutic potential by systematically screening candidates in a diverse array of validated in vivo disease models.

Also known as: Melior, Melior Discovery, Inc., Melior Inc

Primary location: Exton United States